Sunshine Biopharma stock tumbles on $6 million dilutive offering
Investing.com Gold reports: Sunshine Biopharma stock tumbles on $6 million dilutive offering. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Sunshine Biopharma stock tumbles on $6 million dilutive offering. Full body text was unavailable at ingest time, so this brief is based on headline context.